JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CO
6201
DELISTED
Global Cord Blood Corporation
CO
| $2K | ﹤0.01% |
+800
| New | +$2K |
2023 Q1
0 quarters
|
|
|
GEEXU
6202
DELISTED
Games & Esports Experience Acquisition Corp. Unit
GEEXU
| $2K | ﹤0.01% |
+203
| New | +$2.15K |
2023 Q1
0 quarters
|
|
6203
iShares Global Timber & Forestry ETF
WOOD
$255M
| $1.91K | ﹤0.01% |
+27
| New | +$2.01K |
2023 Q1
0 quarters
|
|
6204
WisdomTree International AI Enhanced Value Fund
AIVI
$60.3M
| $1.9K | ﹤0.01% |
+49
| New | +$1.88K |
2023 Q1
0 quarters
|
|
6205
iShares iBonds Dec 2027 Term Muni Bond ETF
IBMP
$669M
| $1.86K | ﹤0.01% |
+73
| New | +$1.85K |
2023 Q1
0 quarters
|
|
6206
Achieve Life Sciences
ACHV
$746M
| $1.7K | ﹤0.01% |
+250
| New | +$1.19K |
2023 Q1
0 quarters
|
|
6207
Richardson Electronics
RELL
$282M
| $1.67K | ﹤0.01% |
+75
| New | +$1.66K |
2023 Q1
0 quarters
|
|
|
AFEM
6208
First Trust Exchange-Traded Fund III First Trust Active Factor Emerging Markets ETF
AFEM
$84M
| $1.58K | ﹤0.01% |
+30
| New | +$1.61K |
2023 Q1
0 quarters
|
|
6209
iShares Self-Driving EV and Tech ETF
IDRV
$283M
| $1.54K | ﹤0.01% |
40
-869
| -96% | -$33.4K |
2022 Q3
2 quarters
|
|
6210
Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF
QDPL
$1.82B
| $1.5K | ﹤0.01% |
+50
| New | +$1.49K |
2023 Q1
0 quarters
|
|
6211
Innovator Uncapped Accelerated US Equity ETF
XUSP
$52.7M
| $1.3K | ﹤0.01% |
+50
| New | +$1.27K |
2023 Q1
0 quarters
|
|
6212
First Trust Dow Jones Select MicroCap Index Fund
FDM
$262M
| $1.29K | ﹤0.01% |
24
| – | – |
2022 Q4
1 quarter
|
|
6213
Invesco MSCI Global Timber ETF
CUT
$29M
| $1.27K | ﹤0.01% |
49
-15
| -23% | -$462 |
2021 Q1
8 quarters
|
|
6214
Capri Holdings
CPRI
$1.64B
| $1.22K | ﹤0.01% |
26
| – | – |
2022 Q4
1 quarter
|
|
6215
Cambria Global Real Estate ETF
BLDG
$51.4M
| $1.22K | ﹤0.01% |
49
-26
| -35% | -$685 |
2022 Q4
1 quarter
|
|
6216
TherapeuticsMD
TXMD
$23.7M
| $1.19K | ﹤0.01% |
363
-113
| -24% | -$542 |
2015 Q1
32 quarters
|
|
6217
Capital Group Global Growth Equity ETF
CGGO
$12B
| $1.15K | ﹤0.01% |
+50
| New | +$1.12K |
2023 Q1
0 quarters
|
|
6218
Global X Dow 30 Covered Call ETF
DJIA
$188M
| $1.1K | ﹤0.01% |
51
+4
| +9% | +$88 |
2022 Q4
1 quarter
|
|
6219
NYLIM Merger Arbitrage ETF
MNA
$266M
| $1.06K | ﹤0.01% |
33
-7,351
| -100% | -$231K |
2022 Q4
1 quarter
|
|
6220
Applied Optoelectronics
AAOI
$9.81B
| $1K | ﹤0.01% |
336
| – | – |
2016 Q3
26 quarters
|
|
6221
Ascent Industries
ACNT
$124M
| $1K | ﹤0.01% |
128
+100
| +357% | +$1.01K |
2018 Q2
19 quarters
|
|
6222
Aldeyra Therapeutics
ALDX
$70.6M
| $1K | ﹤0.01% |
73
| – | – |
2017 Q4
21 quarters
|
|
6223
Aligos Therapeutics
ALGS
$34.6M
| $1K | ﹤0.01% |
27
| – | – |
2020 Q4
9 quarters
|
|
6224
BBVA Argentina
BBAR
$2.53B
| $1K | ﹤0.01% |
256
-1
| -0.4% | -$4 |
2020 Q3
10 quarters
|
|
|
BBU
6225
DELISTED
Brookfield Business Partners
BBU
| $1K | ﹤0.01% |
95
-6,050
| -98% | -$112K |
2016 Q2
27 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.